News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Foto de Raquel Márquez, Key Account Mánager de España y Portugal de Kirsch Pharma
#NewAseBioMember | “This partnership gives us the possibility to establish key contacts and collaborate with leading companies in the sector”
Healthcare · Access to innovation · Innovative drugs · Personalized medicine · Advanced therapies
Meet Kirsch Pharma, our new member. We talked to its Raquel Márquez Duro, Key…
AseBio - Kirsch Pharma España
Foto de Miriam Rubio de Santos, Lilly España
Biotechnology revolutionizes advances against obesity: enhanced understanding, more accurate diagnosis, and development of innovative drugs
Healthcare · Access to innovation
To address how biotechnology is enabling progress in combating obesity from various perspectives,…
Debate sobre la situación de la bioeconomía en España en el marco del AseBio Investor Day
Effective and flexible regulatory policies, increased investment in R&D, and social awareness are pending tasks for Spain in the development of the bioeconomy
Agrifood · Food & feed · Agriculture · Bioeconomy · Circular economy
At the regulatory and political level, Spain has had the Integral Bioeconomy Strategy since 2015,…
Autoridades en la inauguración del AseBio Investor Day 2024
Spanish biotechs raise 228 million euros in private financing in 2023
Financing
During the AseBio Investor Day, held on May 15th in San Sebastián, AseBio has revealed data on…
Foto de Hector Olabegogeaskoetxea, director general de MONDRAGON Health
#AseBioID24 | “Being present at Investor Day gives you wings to visualize, work and promote new developments and be part of the trends of the future.”
Healthcare · Access to innovation · Advanced therapies · Financing
Hector Olabegogeaskoetxea Narbaiza, CEO of MONDRAGON Health, Silver Sponsor of AseBio Investor Day…
Foto de David Roberto, director financiero de Laminar Pharma
#AseBioID24 | "These types of events are essential, considering how difficult it usually is to access financing"
Healthcare · Financing
We analyze the challenges that biotechnology companies face in terms of financing, with David…
AseBio - Laminar Pharma
Foto de Marc Ramoneda, Partner & CEO de Appliant
#NewMemberAseBio | “AseBio offers a portfolio an interesting portfolio of services that fits into our current needs”
Digitalization · Corporate
Meet Appliant, our new member. We talked to its Marc Ramoneda, Partner & CEO.
AseBio - Appliant
Foto de Roger Pique, General Partner de Inveready
#AseBioID24 | 'The Investor Day is a reference event for the national ecosystem primarily, but also internationally"
Healthcare · Financing
We interviewed Roger Pique, General Partner at Inveready, Bronze Sponsor of the AseBio Investor Day…
AseBio - Inveready
Una foto de una dosis de una vacuna
The synergy between biotechnology and immunology catalyzes the development of more effective vaccines and personalized immunological therapies: a new horizon for addressing autoimmune diseases, cancer, and infectious pathologies
Healthcare · Drug discovery · Innovative drugs · Personalized medicine · Advanced therapies
Biotechnology has achieved significant advances in diagnosis and precision therapies, the…